Factor XII (Hageman factor) deficiency

Sections:
  • Definition
  • Causes
  • Symptoms
  • Exams and Tests
  • Treatment
  • Outlook (Prognosis)
  • Possible Complications
  • When to Contact a Medical Professional
  • Prevention
  • References
  • Definition

    Factor XII deficiency is an inherited disorder that affects a protein (factor XII) involved in blood clotting.

    (Return to top)

    Causes

    When you bleed, the body launches a series of reactions that help the blood clot. This is called the coagulation cascade. The process involves special proteins called coagulation factors. (Factor XII is a coagulation factor in this series of reactions.)

    Each factor has a reaction that triggers the next reaction. The final product of the coagulation cascade is the blood clot.

    A lack of factor XII does not cause the affected person to bleed abnormally, but the blood takes longer than normal to clot in a test tube.

    Factor XII deficiency is a rare inherited disorder.

    (Return to top)

    Symptoms

    There are usually no symptoms.

    (Return to top)

    Exams and Tests

    Factor XII deficiency is usually found when clotting tests are done for routine screening.

    Tests may include:

    (Return to top)

    Treatment

    Treatment is generally unnecessary.

    (Return to top)

    Outlook (Prognosis)

    The outcome is expected to be good without treatment.

    (Return to top)

    Possible Complications

    There are usually no complications.

    (Return to top)

    When to Contact a Medical Professional

    This condition is usually discovered by the health care provider, when prolonged clotting is noticed in the process of running other laboratory tests.

    (Return to top)

    Prevention

    This is an inherited disorder. There is no known way to prevent it.

    (Return to top)

    References

    Kessler C. Hemorrhagic disorders: Coagulation factor deficiencies. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 180.

    (Return to top)

    Review Date: 3/2/2009
    Reviewed By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
    The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
    adam.com